Skip to main content

CERES@WPI Virtual Open House

Thursday, June 23, 2022
12:00 pm to 2:00 pm

CERES@WPI Virtual Open House

Thursday, June 23, 12:00pm EST

https://wpi.zoom.us/j/93153931145

Meeting ID: 931 5393 1145

CERES@WPI is a Fee-For-Use Service Center that supports automated cell handling and analysis, located next door at 50 Prescott Street. Core capabilities include:

  • Flow cytometry
  • Automated droplet digital PCR (the only fee-for-use automated ddPCR system we are aware of in the region)
  • Automated fluorescence microscopy
  • Multimode plate readers (with live cell imaging capability – CO2 and N2/hypoxia module installed)
  • Automated liquid handling (pipet-based and acoustic)

https://www.wpi.edu/research/core-research-facilities/ceres

Follow the link above for instructions to create an iLab account for scheduling and invoicing.  Approved usage fees and equipment list attached. 

Please email one of us, or ceres@wpi.edu with questions.  “See” you at the open house!

CERES@WPI Co-Directors:

Marsha Rolle, Ph.D.

Professor, Biomedical Engineering

mrolle@wpi.edu

Eric Young, Ph.D.

Leonard P. Kinnicutt Assistant Professor, Chemical Engineering

emyoung@wpi.edu

Cell Engineering Research and Equipment Suite (CERES @WPI).  CERES is a fee-for-use facility designed to provide WPI researchers and regional industry and academic partners access to state-of-the-art instruments for quantitative analysis of engineered cells. This facility is of broad interest to researchers and companies developing cell and gene therapies, engineering cells to manufacture commercially valuable products, defining critical quality attributes (CQAs) for cell, gene therapy, and biomolecule analysis and characterization, among many other applications. In addition, the facility will accelerate research probing fundamental mechanisms of cell and tissue biology with applications in cancer, immunology, cardiovascular disease, infectious disease, synthetic biology, tissue engineering and regenerative medicine.  CERES was funded by a 2020 Open Capital Award from the Massachusetts Life Sciences Center (MLSC) and designed in collaboration with Massachusetts Biomedical Initiatives (MBI).

Name: 
Marsha Rolle, Ph.D.